Comparison of nasal intermittent positive pressure ventilation and nasal continuous positive airway pressure treatments using parametric survival models. 2014

Mohammad-Reza Baneshi, and Bahareh Bahmanbijari, and Reza Mahdian, and Saeide Haji-Maghsoodi, and Roya Nikbakht
Research Center for Modeling in Health, Institute for Futures Studies in Health.

OBJECTIVE The Cox model is the dominant tool in clinical trials to compare treatment options. This model does not specify any specific form to the hazard function. On the other hand, parametric models allow the researcher to consider an appropriate shape of hazard function for the event of interest. The aim of this article is to compare performance of Cox and parametric models. METHODS We used data collected in a prospective clinical trial that aimed to compare performance of nasal intermittent positive pressure ventilation (NIPPV) and nasal continuous positive airway pressure (NCPAP) treatments in terms of survival of newborn infants who had respiratory distress syndrome (RDS). Performance of Cox, exponential, Weibull, and log-logistic models were compared in terms of goodness of fit. RESULTS Fitting the Cox model, we have seen that infants who received NCPAP were 4.23 (Hazard Ratio= 4.23, 95% Confidence Interval: 1.87-9.59) times more likely to fail than those received NIPPV (P=0.001). Adequacy of the exponential model was rejected. We have seen a decreasing hazard rate over time, in both treatment groups. This decrease was sharper in NCPAP group. Akiake information criterion corresponded to the log-logistic model and was lower than all other models followed by Weibull model. CONCLUSIONS Our results demonstrate the benefit of parametric survival models over traditional Cox regression model in terms of modeling of shape of hazard function. We saw a decreasing hazard that confirms the flexibility of parametric models in terms of the modeling of hazard rate.

UI MeSH Term Description Entries

Related Publications

Mohammad-Reza Baneshi, and Bahareh Bahmanbijari, and Reza Mahdian, and Saeide Haji-Maghsoodi, and Roya Nikbakht
September 2013, JAMA pediatrics,
Mohammad-Reza Baneshi, and Bahareh Bahmanbijari, and Reza Mahdian, and Saeide Haji-Maghsoodi, and Roya Nikbakht
September 2013, JAMA pediatrics,
Mohammad-Reza Baneshi, and Bahareh Bahmanbijari, and Reza Mahdian, and Saeide Haji-Maghsoodi, and Roya Nikbakht
August 2019, Journal of tropical pediatrics,
Mohammad-Reza Baneshi, and Bahareh Bahmanbijari, and Reza Mahdian, and Saeide Haji-Maghsoodi, and Roya Nikbakht
January 2000, The Cochrane database of systematic reviews,
Mohammad-Reza Baneshi, and Bahareh Bahmanbijari, and Reza Mahdian, and Saeide Haji-Maghsoodi, and Roya Nikbakht
January 2002, The Cochrane database of systematic reviews,
Mohammad-Reza Baneshi, and Bahareh Bahmanbijari, and Reza Mahdian, and Saeide Haji-Maghsoodi, and Roya Nikbakht
September 2009, Acta paediatrica (Oslo, Norway : 1992),
Mohammad-Reza Baneshi, and Bahareh Bahmanbijari, and Reza Mahdian, and Saeide Haji-Maghsoodi, and Roya Nikbakht
October 1989, American journal of diseases of children (1960),
Mohammad-Reza Baneshi, and Bahareh Bahmanbijari, and Reza Mahdian, and Saeide Haji-Maghsoodi, and Roya Nikbakht
December 2016, The Cochrane database of systematic reviews,
Mohammad-Reza Baneshi, and Bahareh Bahmanbijari, and Reza Mahdian, and Saeide Haji-Maghsoodi, and Roya Nikbakht
February 2017, The Cochrane database of systematic reviews,
Mohammad-Reza Baneshi, and Bahareh Bahmanbijari, and Reza Mahdian, and Saeide Haji-Maghsoodi, and Roya Nikbakht
January 2001, The Cochrane database of systematic reviews,
Copied contents to your clipboard!